← Leaderboards
Barbara Brigitta Bendlin
University Of Wisconsin-Madison
$36,811,854
Attributed
$69,455,299
Total exposure
17
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.6M · FY2012–25$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$69,455,299 · 17
By mechanism
R01$52,904,353 · 6
UF1$5,849,254 · 1
RF1$5,602,567 · 2
P30$1,622,397 · 2
R56$1,506,269 · 2
R21$828,395 · 2
Top collaborators
- Federico E Rey14 shared
- Tyler Kent Ulland11 shared
- Amy J. Kind8 shared
- Bradley T Christian6 shared
- Sterling C Johnson6 shared
- Vikas Singh3 shared
- Randall J Gretebeck2 shared
- Shi-Jiang Li2 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Lev A Borisov$799,398
- Laurentiu G Maxim$397,718
- Ken Ono$4,944,401
- Percival Grant Matthews$1,087,645
- Rajesh S Kulkarni$941,046
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseWisconsinBrainAmyloidParticipantBiological MarkersTau ProteinsPathologyCognitiveDementiaNerve DegenerationLinkImpaired CognitionPositron-Emission TomographyNeuropathologyIndexingSuccessSamplingBaseAlzheimerâS Disease BiomarkerIn VivoNeuroimagingMagnetic Resonance Imaging
Grant awards (57)
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)$5,172,719
R01 · FY2025 · AG
Ã-hydroxybutyrate inhibition of pathology in Alzheimer's disease$742,345
R01 · FY2025 · AG
Gut barrier function in Alzheimerâs disease$724,177
R01 · FY2025 · AG · contact PI
Gut microbiome intervention in preclinical and clinical Alzheimer's disease$450,045
R61 · FY2025 · AG · contact PI
CRCNS: Repurposing Transformers to Characterize Gut Microbiome & Aging Brain Axis$362,434
R01 · FY2025 · AG
REC - Research Education Core$252,501
P30 · FY2025 · AG · contact PI
Exploring the role of Imidazole Propionate on Alzheimerâs Disease and Related Dementias$184,385
R21 · FY2025 · AG
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)$5,847,113
R01 · FY2024 · AG
Ã-hydroxybutyrate inhibition of pathology in Alzheimer's disease$752,364
R01 · FY2024 · AG
Gut barrier function in Alzheimerâs disease$740,468
R01 · FY2024 · AG · contact PI
CRCNS: Repurposing Transformers to Characterize Gut Microbiome & Aging Brain Axis$369,886
R01 · FY2024 · AG
REC - Research Education Core$252,501
P30 · FY2024 · AG · contact PI
Gut barrier function in Alzheimer's Disease$249,997
R01 · FY2024 · AG · contact PI
Exploring the role of Imidazole Propionate on Alzheimerâs Disease and Related Dementias$223,260
R21 · FY2024 · AG
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)$6,354,915
R01 · FY2023 · AG
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)$3,494,004
R01 · FY2023 · AG
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$756,180
R01 · FY2023 · AG · contact PI
Ã-hydroxybutyrate inhibition of pathology in Alzheimer's disease$752,364
R01 · FY2023 · AG
Gut barrier function in Alzheimerâs disease$739,920
R01 · FY2023 · AG · contact PI
Research Education Component$215,007
P30 · FY2023 · AG · contact PI
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)$6,308,069
R01 · FY2022 · AG
Administrative Supplement to Establish National Exposome Alzheimer's Disease and Related Dementias (ADRD) Infrastructure (Expo-AD)$3,451,498
R01 · FY2022 · AG
SV2A PET imaging in Alzheimer's Disease$1,129,244
R01 · FY2022 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$760,068
R01 · FY2022 · AG · contact PI
Gut barrier function in Alzheimerâs disease$748,156
R01 · FY2022 · AG · contact PI
Research Education Component$222,638
P30 · FY2022 · AG · contact PI
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)$4,760,115
R01 · FY2021 · AG
SV2A PET imaging in Alzheimer's Disease$1,131,446
R01 · FY2021 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$761,218
R01 · FY2021 · AG · contact PI
Gut barrier function in Alzheimerâs disease$742,527
R01 · FY2021 · AG · contact PI
Research Education Component$217,832
P30 · FY2021 · AG · contact PI
SV2A PET imaging in Alzheimer's Disease$1,133,380
R01 · FY2020 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$759,193
R01 · FY2020 · AG · contact PI
Research Education Component$246,910
P30 · FY2020 · AG · contact PI
Algebraic Formulations for Characterizing Structural Brain Connectivity Changes and Pathology Transmission Networks in Preclinical Alzheimer's Disease$1,826,486
RF1 · FY2019 · AG
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$759,193
R01 · FY2019 · AG · contact PI
SV2A PET imaging in Alzheimer's Disease$755,504
R01 · FY2019 · AG · contact PI
SV2A PET imaging in Alzheimer's Disease$380,731
R01 · FY2019 · AG · contact PI
Alzheimer's Disease Connectome Project$329,245
UF1 · FY2019 · AG
Research Education Component$215,008
P30 · FY2019 · AG · contact PI
SV2A PET imaging in Alzheimer's Disease$758,565
R01 · FY2018 · AG · contact PI
Midlife Insulin Resistance and Obesity: Risk Factors for AD-Related Brain Change$161,440
P50 · FY2018 · AG · contact PI
Neighborhood Socioeconomic Contextual Disadvantage and Alzheimer's Disease$3,776,081
RF1 · FY2017 · AG
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$758,631
R56 · FY2017 · AG · contact PI
Diet and Exercise Trial to Improve Insulin Resistance, Increase Cerebral Blood Flow, Alter Metabolomic Biomarkers, and Decrease Alzheimer's Disease Risk$191,250
R21 · FY2017 · AG · contact PI
Midlife Insulin Resistance and Obesity: Risk Factors for AD-Related Brain Change$133,429
P50 · FY2017 · AG · contact PI
Alzheimer's Disease Connectome Project$5,520,009
UF1 · FY2016 · AG
Apnea and local sleep: Mechanism and intervention in preclinical Alzheimer's$747,638
R56 · FY2016 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$305,212
R01 · FY2016 · AG · contact PI
Diet and Exercise Trial to Improve Insulin Resistance, Increase Cerebral Blood Flow, Alter Metabolomic Biomarkers, and Decrease Alzheimer's Disease Risk$229,500
R21 · FY2016 · AG
Midlife Insulin Resistance and Obesity: Risk Factors for AD-Related Brain Change$134,320
P50 · FY2016 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$296,055
R01 · FY2015 · AG · contact PI
Midlife Insulin Resistance and Obesity: Risk Factors for AD-Related Brain Change$129,425
P50 · FY2015 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$305,212
R01 · FY2014 · AG · contact PI
Midlife Insulin Resistance and Obesity: Risk Factors for AD-Related Brain Change$133,405
P50 · FY2014 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$291,556
R01 · FY2013 · AG · contact PI
White matter degeneration: biomarkers in preclinical Alzheimer's Disease$308,525
R01 · FY2012 · AG · contact PI